Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Chaitchik

Showing results (91-100 of 114) with videos related to

Pageof 12
Sort By:
Harefuah|May 2, 1993
[Chemofiltration for locally advanced cancer]M Gutman, P Sorkin, S Chaitchik, et al.
Acta Obstetricia Et Gynecologica Scandinavica|September 1, 1994
Use of CA-125 response to predict survival parameters of patients with advanced ovarian carcinomaI G Ron, M Inbar, I Gelernter, et al.
Oncology Reports|May 20, 2011
Fluorescence polarization changes in the lymphocytic cytoplasm in the various stages of breast cancerI Ron, M Deutsch, O Merimsky, et al.
European Journal of Cancer (Oxford, England : 1990)|September 1, 1996
Adaptation of the cellscan technique for the SCM test in breast cancerH Rahmani, M Deutsch, I Ron, et al.
Melanoma Research|April 1, 1996
Intra-arterial chemotherapy with concomitant hemofiltration (chemofiltration) for treatment of loco-regional or pelvic metastases from malignant melanomaM Gutman, S Abu-Abid, M Inbar, et al.
Biological Trace Element Research|September 1, 1994
The distribution of BrK alpha/RbK alpha peak intensity ratio in human whole blood samples. Comparison between normal and colorectal cancer casesC Shenberg, S Spiegel, S Chaitchik, et al.
Oncology Reports|May 19, 2011
Amputation of the lower limb as palliative treatment for debilitating musculoskeletal cancerO Merimsky, Y Kollender, J Bickels, et al.
Molecular Biotherapy|September 1, 1990
Phase II study of recombinant interferon alpha-C in patients with metastatic renal cell carcinomaO Merimsky, M Inbar, E Merimsky, et al.
American Journal of Clinical Oncology|December 1, 1996
Melanoma-associated hypopigmentation: where are the antibodies?O Merimsky, Y Shoenfeld, E Baharav, et al.
Cancer|August 1, 1991
Are malignant melanoma patients at higher risk for a second cancer?M Gutman, A Cnaan, M Inbar, et al.
Pageof 12

Showing results (91-100 of 114) with videos related to

Sort By:
Pageof 12
Harefuah|May 2, 1993
[Chemofiltration for locally advanced cancer]M Gutman, P Sorkin, S Chaitchik, et al.
Acta Obstetricia Et Gynecologica Scandinavica|September 1, 1994
Use of CA-125 response to predict survival parameters of patients with advanced ovarian carcinomaI G Ron, M Inbar, I Gelernter, et al.
Oncology Reports|May 20, 2011
Fluorescence polarization changes in the lymphocytic cytoplasm in the various stages of breast cancerI Ron, M Deutsch, O Merimsky, et al.
European Journal of Cancer (Oxford, England : 1990)|September 1, 1996
Adaptation of the cellscan technique for the SCM test in breast cancerH Rahmani, M Deutsch, I Ron, et al.
Melanoma Research|April 1, 1996
Intra-arterial chemotherapy with concomitant hemofiltration (chemofiltration) for treatment of loco-regional or pelvic metastases from malignant melanomaM Gutman, S Abu-Abid, M Inbar, et al.
Biological Trace Element Research|September 1, 1994
The distribution of BrK alpha/RbK alpha peak intensity ratio in human whole blood samples. Comparison between normal and colorectal cancer casesC Shenberg, S Spiegel, S Chaitchik, et al.
Oncology Reports|May 19, 2011
Amputation of the lower limb as palliative treatment for debilitating musculoskeletal cancerO Merimsky, Y Kollender, J Bickels, et al.
Molecular Biotherapy|September 1, 1990
Phase II study of recombinant interferon alpha-C in patients with metastatic renal cell carcinomaO Merimsky, M Inbar, E Merimsky, et al.
American Journal of Clinical Oncology|December 1, 1996
Melanoma-associated hypopigmentation: where are the antibodies?O Merimsky, Y Shoenfeld, E Baharav, et al.
Cancer|August 1, 1991
Are malignant melanoma patients at higher risk for a second cancer?M Gutman, A Cnaan, M Inbar, et al.
Pageof 12